In addition to the comparison of cfDNA mutation and methylation results at baseline and after neoadjuvant therapy, longitudinal cfDNA integrity analysis was also shown to be suitable to indicate tumor shrinkage and reduced Ki67 levels in case the cfDNA integrity increased [79]. Here, MKI67 is linked to neoplasm.